Is Very Long Chain Acyl CoA Dehydrogenase Deficiency (LCAD) hereditary?

Very Long Chain Acyl CoA Dehydrogenase Deficiency (LCAD) is a rare genetic disorder that affects the body's ability to break down certain fats for energy. It is caused by mutations in the ACADVL gene, which is responsible for producing an enzyme called very long chain acyl CoA dehydrogenase.

This condition is hereditary, meaning it is passed down from parents to their children through their genes. LCAD follows an autosomal recessive pattern of inheritance, which means that both parents must carry a mutated copy of the ACADVL gene in order for their child to be affected.

When both parents are carriers, there is a 25% chance with each pregnancy that their child will inherit two mutated copies of the gene and develop LCAD. Individuals who inherit two normal copies of the gene are unaffected carriers, while those who inherit one normal and one mutated copy are typically healthy carriers.

LCAD deficiency can lead to a variety of symptoms, including low blood sugar, muscle weakness, liver problems, and heart abnormalities. The severity of the condition can vary widely, with some individuals experiencing mild symptoms and others facing life-threatening complications.

Diagnosis of LCAD is typically made through genetic testing, which can identify mutations in the ACADVL gene. Treatment involves managing symptoms and preventing complications through a combination of dietary modifications, regular monitoring, and medical interventions as needed.